Interview: Elizabeth Plaza – Founder & Chairwoman of the Board,…
Prevention versus remediation is the name of the game in regulatory and compliance issues for pharmaceutical manufacturers; the cost of non-compliance is much higher than investing proactively in compliance. Elizabeth…